Dropless Pars Plana Vitrectomy Study

Condition:   Rhegmatogenous Retinal Detachment Interventions:   Procedure: Pars plana vitrectomy;   Drug: Triamcinolone Acetonide 40mg/mL;   Drug: Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin;   Drug: Prednisolone 1%;   Drug: Atropine 1% Sponsor:   Massachusetts Eye and Ear Infirmary Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials